Global Industry Analysts, Inc., March 2008, Pages: 264
... Initiates Endeavor Clinical Trials for Endeavor Drug Eluting Stent II-21 ... MIV Commences Clinical Trials of HC Stent II-21 ... I Trial Program of NX? DES System II ...
Global Markets Direct, Jan 2009, Pages: 40
... Announces First CE Certified Nobori DES In Use ... 2007: Terumo?s Nobori Drug Eluting Stent System Continues ... Summary Of Duraheart LVAD Clinical Trial Results 29 ...
Global Markets Direct, Jan 2009, Pages: 41
... 2008: BIOTRONIK Announces Positive Clinical Trial Results At ... Completes Enrollment Of DES Trial 38 4.3 ... I First-In-Man Pimecrolimus Drug Eluting Stent Trial 38 5 ...
Frost & Sullivan, Dec 2005 ... Increase of Patient Awareness Drives Uptake for Stenting Procedures 5 ... Market Restraints 1. Restraints a. Limited Drug Eluting Stents (DES) Data Impacting ...
Koncept Analytics, May 2009, Pages: 41
... Bare metal stents (BMS) and drug-eluting stents are the ... The report analyzes the coronary stent market from two ... point of products, ie, BMS and DES market size ...
GlobalData, June 2008, Pages: 18
... Announces First CE Certified Nobori DES In Use ... 2: Bare Metal Stent and Drug Eluting Stent Market, Comparative ... 2012 8 Figure 3: ABSORB Clinical Trial Outcomes 9 ...
Bizacumen Inc., Nov 2009, Pages: 141
... Players and their DES Development Efforts ... in Angioplasty Procedures Vs Stent Penetration Worldwide ... Breakdown of Leading Drug-Eluting Stent Manufacturer Revenues ...
Decision Resources, Inc., Feb 2005, Pages: 89
... lacks a presence in the expanding drug-eluting stent (DES) area ... companies with both CRM and stent programs, have ... Sorin recently launched its DES in Europe, and ...
Business Insights, Aug 2007, Pages: 182
... Polymers Further Coronary Stent Developments and ... of Novel Estradiol Containing Drug-Eluting Stents Stem ... and Emerging Cardiovascular Drugs Summary Introduction ...
GlobalData, May 2008, Pages: 13
... 5 3 Xience V - Leapfrogging to Lead DES Market in ... Treated With Abbotts XIENCE V Drug Eluting Stent Experience Better ... Approval for TAXUS Liberte Stent System 9 ...
Medtech Ventures, Feb 2008, Pages: 30
... safety and efficacy of DES, and challenged earlier negative late stent thrombosis results ... With Drug Eluting Stents - Technology & Market Forecast ...
Espicom Business Intelligence Ltd, Aug 2009, Pages: 42
... Cordis' Position in US DES Market, Q109 ... Neuroscience Business LITIGATION - Positive Stent Patent Litigation ... Quarter 2009 Sales of Drug-Eluting Stents - Cordis ...
Informa Healthcare, Jan 2007, Pages: 282
... a battle for dominance of the drug eluting stent market ... alloy: the Xience V everolimus-eluting coronary stent... V is slightly more effective than the Taxus stent. ...
Global Industry Analysts, Inc., Oct 2008, Pages: 257
... with Medtronic II-49 Medtronic Sublicenses DES Coating Technology ...Stent, XIENCE? V Over TAXUS® Stent II-53 ... Low Mortality Rates for Both Drug-Eluting And Bare ...
Global Markets Direct, May 2009, Pages: 227
... Bare Metal Stent 3.7.4.2 Drug Eluting Stent (DES) 3.7.5 ... 2015) 14.2.2 Coronary Stent Overall Volume ... GE Healthcare Pipeline Products By Clinical Trials 16.8.2.5 ...
Global Markets Direct, May 2009, Pages: 231
... 4.1 Bare Metal Stent 3.7.4.2 Drug Eluting Stent (DES) 3.7.5 ... 2000-2015) 14.2.2 Coronary Stent Overall Volume ... Pipeline Products By Clinical Trials 16.20 ev3 Inc. ...
